Placeholder Banner

BIO Letter to White House on Need for Animal Biotech Reform in Wake of COVID-19

April 7, 2020

As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.

Download Full Comments Below
BIO Greenwood Letter to President Trump on Animal Biotech
Discover More
On behalf of the Animal Agriculture Coalition (AAC), representing veterinary medicine, animal science, state agricultural leaders, and various livestock or animal agricultural interests in the U.S., we applaud lawmakers’ ongoing attention to the…
As Congress develops and debates additional bipartisan legislation in response to COVID-19 and the resulting impacts to workers and the economy, the economic losses persisting across U.S. agriculture must be addressed in the legislation and in…
The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation…